Seoul National University Hospital: Carcinoma, Renal Cell trials

The registry lists 10 Carcinoma, Renal Cell studies with Seoul National University Hospital as lead sponsor. 1 are open to participants now and 0 have results posted.

Phase 2 3No phase 7(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Immediate Versus Deferred Cytoreductive Nephrectomy With Ipilimumab/Nivolumab in mRCCNot yet recruitingNCT07233668Not applicable
• Anesthesia and Cancer Study: Renal Cell CarcinomaActive, not recruitingNCT04503148Not applicable
• Prognostic Significance of Preoperative Hemoglobin A1c (HbA1c) in Renal Cell CarcinomaStatus unknownNCT02417194
• The Intrathecal Morphine for NephrectomyCompletedNCT01997788Not applicable
• Irradiated Donor Lymphocyte Infusion Plus High-dose IL-2TerminatedNCT01925118Phase 2
• A Phase II Study of Axitinib in Metastatic Non-clear Cell Renal Cell Carcinoma Patients Previously Treated With TemsirolimusCompletedNCT01798446Phase 2
• Prognostic Factor for Renal Cell Carcinoma (RCC) With Venous Tumor ThrombusCompletedNCT01328691
• Detection of Renal Malignancy of Complicated Renal CystsCompletedNCT01087060
• Laparoendoscopic Single-site Radical Nephrectomy for Localized Renal Cell CarcinomaStatus unknownNCT00945984
• RAD001 for Non-clear Cell Renal Cell Carcinoma (RCC)CompletedNCT00830895Phase 2